ERBB2 and breast carcinoma: We have previously reported that a high number of M2 TAMs was associated with poor overall survival (OS) among HER2+ breast cancer patients [19], whereas other researchers have reported no significant correlation between M2 TAM numbers and survival in this breast cancer subtype [20,21].